Antibodies | sciencenewsnet.in

Ending the Pandemic

April 1, 2020 sarah Jonas Antibodies, Coronavirus, COVID-19, Immunity, Immunology, Infection, Pandemic, Vaccines, Virus

As scientists forge ahead to piece together a comprehensive profile of the new coronavirus fueling a historic pandemic, they are focusing their efforts on six areas: epidemiology, diagnostics, pathogenesis, clinical disease management, treatment and vaccines.

Feature

Virus-Scanning Tool Could Detect Previous COVID-19 Infections and Inform Vaccine Development

March 31, 2020 sarah Jonas Antibodies, Coronavirus, coronavirus test, coronavirus testing, coronavirus vaccine, COVID-19, SARS-CoV-2, SARS-CoV-2 testing

Using a research assay called VirScan, scientists plan to study how antibodies from people who have had COVID-19 attack the virus that causes it.

Research Results

Learning from the Recovered

March 26, 2020 sarah Jonas Antibodies, Coronavirus, COVID-19, Immune System, Immunity, Pandemic

Researchers at Harvard Medical School and at Brigham and Women’s Hospital are adapting an antibody-detection tool to study the aftermath of infections by the novel coronavirus that is causing the current global pandemic.

Research Results

INFECTIOUS DISEASE EXPERTS RECOMMEND USING ANTIBODIES FROM COVID-19 SURVIVORS AS STOPGAP MEASURE TO TREAT PATIENTS AND PROTECT HEALTH CARE WORKERS

March 13, 2020 sarah Jonas Antibodies, Coronavirus, COVID-19, novel coronavirus, SARS-CoV-2

Countries fighting outbreaks of the novel coronavirus disease COVID-19 should consider using the antibodies of people who have recovered from infection to treat cases and provide short-term immunity—lasting weeks to months—to critical health care workers, argue two infectious disease experts.

Research Results

Designer Probiotic Treatment for Cancer Immunotherapy

February 12, 2020 sarah Jonas Antibodies, Bacteria, Cancer, Immunotheapy, probiotic, Tumor

Columbia Engineers have engineered probiotics to safely deliver immunotherapies within tumors, including nanobodies against two proven therapeutic targets—PD-L1 and CTLA-4. Continuously released by bacteria, the drugs continue to attack the tumor after just one dose, facilitating an immune response resulting in tumor regression. The versatile probiotic platform can also be used to deliver multiple immunotherapies simultaneously, enabling the release of effective therapeutic combinations within the tumor for more difficult-to-treat cancers like colorectal cancer.

Research Results

High-Tech Printing May Help Eliminate Painful Shots

February 4, 2020 sarah Jonas 3d printing, Antibodies, Diabetes, DNA, Drugs, Engineering, Enzymes, Health, Hospitals, Infection, Italy, Mechanical Engineering, Medicine, pain, Printing, Rutgers, Rutgers University-New Brunswick, skin, smart materials, Tech, Technology, University of Minnesota

Painful hypodermic needles may not be needed in the future to give shots, inject drugs and get blood samples. With 4D printing, Rutgers engineers have created tiny needles that mimic parasites that attach to skin and could replace hypodermic needles, according to a study in the journal Advanced Functional Materials.